Cargando…

H1/pAIM2 nanoparticles exert anti‐tumour effects that is associated with the inflammasome activation in renal carcinoma

Renal cell carcinoma (RCC) is a high metastasis tumour with less effective treatment available currently. Absent in melanoma 2 (AIM2) as a tumour suppressor might be used as a potential therapeutic target for RCC treatment. Here, we found that AIM2 expression was significantly decreased in RCC patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chai, Dafei, Liu, Nianli, Li, Huizhong, Wang, Gang, Song, Jingyuan, Fang, Lin, Lu, Zheng, Yao, Hong, Zheng, Junnian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201339/ https://www.ncbi.nlm.nih.gov/pubmed/30160343 http://dx.doi.org/10.1111/jcmm.13842

Ejemplares similares

Absent in melanoma 2 enhances anti‐tumour effects of CAIX promotor controlled conditionally replicative adenovirus in renal cancer
por: Chai, Dafei, et al.
Publicado: (2020)

iNKT: A new avenue for CAR-based cancer immunotherapy
por: Liu, Yilin, et al.
Publicado: (2022)

ISG12a and its interaction partner NR4A1 are involved in TRAIL‐induced apoptosis in hepatoma cells
por: Liu, Nianli, et al.
Publicado: (2019)

Therapeutic Adenovirus Vaccine Combined Immunization with IL-12 Induces Potent CD8(+) T Cell Anti-Tumor Immunity in Hepatocellular Carcinoma
por: Zheng, Yanyan, et al.
Publicado: (2022)

The Anti-fibrosis drug Pirfenidone modifies the immunosuppressive tumor microenvironment and prevents the progression of renal cell carcinoma by inhibiting tumor autocrine TGF-β
por: Wang, Gang, et al.
Publicado: (2022)

The optimization system for preparation of TG1 competent cells and electrotransformation
por: Chai, Dafei, et al.
Publicado: (2020)

Synergistic Effects of Cabozantinib and EGFR-Specific CAR-NK-92 Cells in Renal Cell Carcinoma
por: Zhang, Qing, et al.
Publicado: (2017)

Complement C1q binding protein regulates T cells’ mitochondrial fitness to affect their survival, proliferation, and anti–tumor immune function
por: Tian, Hui, et al.
Publicado: (2022)

H1/pHGFK1 nanoparticles exert anti-tumoural and radiosensitising effects by inhibition of MET in glioblastoma
por: Zhang, Wenyan, et al.
Publicado: (2018)

Absent in melanoma 2-mediating M1 macrophages facilitate tumor rejection in renal carcinoma
por: Chai, Dafei, et al.
Publicado: (2021)

The co-delivery of adenovirus-based immune checkpoint vaccine elicits a potent anti-tumor effect in renal carcinoma
por: Jiang, Nan, et al.
Publicado: (2023)

MBD2 Correlates with a Poor Prognosis and Tumor Progression in Renal Cell Carcinoma
por: Li, Liantao, et al.
Publicado: (2020)

The development of CAR design for tumor CAR-T cell therapy
por: Xu, Dandan, et al.
Publicado: (2018)

Inflammasome-independent functions of AIM2
por: Zhao, Junjie, et al.
Publicado: (2021)

Reassembling of albumin-bound paclitaxel mitigates myelosuppression and improves its antitumoral efficacy via neutrophil-mediated targeting drug delivery
por: Chen, Yuxin, et al.
Publicado: (2022)

Blockade of AIM2 inflammasome or α1-AR ameliorates IL-1β release and macrophage-mediated immunosuppression induced by CAR-T treatment
por: Liu, Dan, et al.
Publicado: (2021)

IFI35 Promotes Renal Cancer Progression by Inhibiting pSTAT1/pSTAT6-Dependent Autophagy
por: Chai, Dafei, et al.
Publicado: (2022)

Co‐immunization with L‐Myc enhances CD8(+) or CD103(+) DCs mediated tumor‐specific multi‐functional CD8(+) T cell responses
por: Chai, Dafei, et al.
Publicado: (2021)

Roles of AIM2 Gene and AIM2 Inflammasome in the Pathogenesis and Treatment of Psoriasis
por: Wang, Jieyi, et al.
Publicado: (2022)

Dual-targeting vaccine of FGL1/CAIX exhibits potent anti-tumor activity by activating DC-mediated multi-functional CD8 T cell immunity
por: Chai, Dafei, et al.
Publicado: (2021)

HMGB1/GPC3 dual targeting vaccine induces dendritic cells-mediated CD8(+)T cell immune response and elicits potential therapeutic effect in hepatocellular carcinoma
por: Shi, Xiaoqing, et al.
Publicado: (2023)

The Role of AIM2 Inflammasome in Knee Osteoarthritis
por: Yang, Jiyong, et al.
Publicado: (2022)

Recombinant oncolytic adenovirus armed with CCL5, IL-12, and IFN-γ promotes CAR-T infiltration and proliferation in vivo to eradicate local and distal tumors
por: Fang, Lin, et al.
Publicado: (2023)

C1QBP regulates mitochondrial plasticity to impact tumor progression and antitumor immune response
por: Wang, Qiping, et al.
Publicado: (2022)

Mitochondrial ROS potentiates indirect activation of the AIM2 inflammasome
por: Crane, Deborah D., et al.
Publicado: (2014)

Structure, Activation and Regulation of NLRP3 and AIM2 Inflammasomes
por: Sharma, Meenakshi, et al.
Publicado: (2021)

Regulatory Cues in Pulmonary Fibrosis—With Emphasis on the AIM2 Inflammasome
por: Tseng, Yu-Hsin, et al.
Publicado: (2023)

Tumor-Penetrating Peptide Enhances Antitumor Effects of IL-24 Against Prostate Cancer
por: Yang, Jie, et al.
Publicado: (2018)

Interaction between HCMV pUL83 and human AIM2 disrupts the activation of the AIM2 inflammasome
por: Huang, Yuan, et al.
Publicado: (2017)

Perfluoroalkyl substance pollutants activate the innate immune system through the AIM2 inflammasome
por: Wang, Li-Qiu, et al.
Publicado: (2021)

AIM2 Inflammasome-Mediated Pyroptosis in Enterovirus A71-Infected Neuronal Cells Restricts Viral Replication
por: Yogarajah, Thinesshwary, et al.
Publicado: (2017)

Peglated-H1/pHGFK1 nanoparticles enhance anti-tumor effects of sorafenib by inhibition of drug-induced autophagy and stemness in renal cell carcinoma
por: Gao, Xiaoge, et al.
Publicado: (2019)

Manipulation of Mitochondrial Plasticity Changes the Metabolic Competition Between “Foe” and “Friend” During Tumor Malignant Transformation
por: Tian, Hui, et al.
Publicado: (2020)

The AIM2 inflammasome is critical for innate immunity against Francisella tularensis
por: Fernandes-Alnemri, Teresa, et al.
Publicado: (2010)

AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA
por: Fernandes-Alnemri, Teresa, et al.
Publicado: (2009)

AIM2 Inflammasome's First Decade of Discovery: Focus on Oral Diseases
por: Wang, Lufei, et al.
Publicado: (2020)

The AIM2 inflammasome is activated in astrocytes during the late phase of EAE
por: Barclay, William E., et al.
Publicado: (2022)

AIM2 Co-immunization with VP1 Is Associated with Increased Memory CD8 T Cells and Mounts Long Lasting Protection against Coxsackievirus B3 Challenge
por: Yin, Liang, et al.
Publicado: (2017)

Correction: Peglated-H1/pHGFK1 nanoparticles enhance anti-tumor effects of sorafenib by inhibition of drug-induced autophagy and stemness in renal cell carcinoma
por: Gao, Xiaoge, et al.
Publicado: (2023)

AIM2 inflammasome mediates Arsenic-induced secretion of IL-1 β and IL-18
por: Zhang, Mingfang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_g86oqbs2esibabmj6et7ipm9fr